Transcend Capital Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-11,534
Closed -$141K – 498
2022
Q4
$141K Buy
11,534
+1,106
+11% +$13.8K 0.02% 468
2022
Q3
$129K Buy
+10,428
New +$182K 0.01% 460

Other funds holding ELAN

Transcend Capital Advisors's ELAN Position: Q1 2023 in Review

Transcend Capital Advisors sold out of Elanco Animal Health (ELAN) in Q1 2023, closing a stake of 11,534 shares — an estimated $141K sold.

Transcend Capital Advisors first reported a position in ELAN in Q3 2022 and held it in 2 quarters. The position peaked at $141K in Q4 2022. 389 funds tracked by Wall St. Rank hold ELAN as of Q1 2023.

  • Transcend Capital Advisors reported no remaining Elanco Animal Health position as of Q1 2023 after selling out during the quarter.
  • Transcend Capital Advisors sold 11,534 Elanco Animal Health shares in Q1 2023, an estimated $141K.
  • Transcend Capital Advisors first reported a position in Elanco Animal Health in Q3 2022 and held it in 2 quarters.
  • Transcend Capital Advisors's Elanco Animal Health position peaked at $141K in Q4 2022.
  • 389 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2023.

Based on Transcend Capital Advisors's 13F filing for Q1 2023, filed 12 Apr 2023.